141 related articles for article (PubMed ID: 34816459)
21. Uncovering the Relationship Between Genes and Phenotypes Beyond the Gut in Microvillus Inclusion Disease.
Sun M; Pylypenko O; Zhou Z; Xu M; Li Q; Houdusse A; van IJzendoorn SCD
Cell Mol Gastroenterol Hepatol; 2024; 17(6):983-1005. PubMed ID: 38307491
[TBL] [Abstract][Full Text] [Related]
22. Lysophosphatidic Acid Increases Maturation of Brush Borders and SGLT1 Activity in MYO5B-deficient Mice, a Model of Microvillus Inclusion Disease.
Kaji I; Roland JT; Watanabe M; Engevik AC; Goldstein AE; Hodges CA; Goldenring JR
Gastroenterology; 2020 Oct; 159(4):1390-1405.e20. PubMed ID: 32534933
[TBL] [Abstract][Full Text] [Related]
23. Loss of syntaxin 3 causes variant microvillus inclusion disease.
Wiegerinck CL; Janecke AR; Schneeberger K; Vogel GF; van Haaften-Visser DY; Escher JC; Adam R; Thöni CE; Pfaller K; Jordan AJ; Weis CA; Nijman IJ; Monroe GR; van Hasselt PM; Cutz E; Klumperman J; Clevers H; Nieuwenhuis EE; Houwen RH; van Haaften G; Hess MW; Huber LA; Stapelbroek JM; Müller T; Middendorp S
Gastroenterology; 2014 Jul; 147(1):65-68.e10. PubMed ID: 24726755
[TBL] [Abstract][Full Text] [Related]
24. An inducible mouse model for microvillus inclusion disease reveals a role for myosin Vb in apical and basolateral trafficking.
Schneeberger K; Vogel GF; Teunissen H; van Ommen DD; Begthel H; El Bouazzaoui L; van Vugt AH; Beekman JM; Klumperman J; Müller T; Janecke A; Gerner P; Huber LA; Hess MW; Clevers H; van Es JH; Nieuwenhuis EE; Middendorp S
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12408-13. PubMed ID: 26392529
[TBL] [Abstract][Full Text] [Related]
25. Loss of MYO5B Leads to Reductions in Na
Engevik AC; Kaji I; Engevik MA; Meyer AR; Weis VG; Goldstein A; Hess MW; Müller T; Koepsell H; Dudeja PK; Tyska M; Huber LA; Shub MD; Ameen N; Goldenring JR
Gastroenterology; 2018 Dec; 155(6):1883-1897.e10. PubMed ID: 30144427
[TBL] [Abstract][Full Text] [Related]
26. Cell differentiation is disrupted by MYO5B loss through Wnt/Notch imbalance.
Kaji I; Roland JT; Rathan-Kumar S; Engevik AC; Burman A; Goldstein AE; Watanabe M; Goldenring JR
JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34197342
[TBL] [Abstract][Full Text] [Related]
27. Microvillus inclusion disease with novel MYO5B pathogenic variants.
Kwon R; Huang J; Oshima K; Warren M; Voltaggio L; Wang Y; Montgomery EA; Hutchings D
Histopathology; 2021 Jul; 79(1):119-121. PubMed ID: 33544913
[No Abstract] [Full Text] [Related]
28. Myo5b knockout mice as a model of microvillus inclusion disease.
Cartón-García F; Overeem AW; Nieto R; Bazzocco S; Dopeso H; Macaya I; Bilic J; Landolfi S; Hernandez-Losa J; Schwartz S; Ramon y Cajal S; van Ijzendoorn SC; Arango D
Sci Rep; 2015 Jul; 5():12312. PubMed ID: 26201991
[TBL] [Abstract][Full Text] [Related]
29. Unequal Effects of Myosin 5B Mutations in Liver and Intestine Determine the Clinical Presentation of Low-Gamma-Glutamyltransferase Cholestasis.
van IJzendoorn SCD; Li Q; Qiu YL; Wang JS; Overeem AW
Hepatology; 2020 Oct; 72(4):1461-1468. PubMed ID: 32583448
[No Abstract] [Full Text] [Related]
30. Microvillus inclusion disease, a diagnosis to consider when abnormal stools and neurological impairments run together due to a rare syntaxin 3 gene mutation.
Julia J; Shui V; Mittal N; Heim-Hall J; Blanco CL
J Neonatal Perinatal Med; 2019; 12(3):313-319. PubMed ID: 30909251
[TBL] [Abstract][Full Text] [Related]
31. Altered MYO5B Function Underlies Microvillus Inclusion Disease: Opportunities for Intervention at a Cellular Level.
Bowman DM; Kaji I; Goldenring JR
Cell Mol Gastroenterol Hepatol; 2022; 14(3):553-565. PubMed ID: 35660026
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in understanding and managing malabsorption: focus on microvillus inclusion disease.
Jayawardena D; Alrefai WA; Dudeja PK; Gill RK
F1000Res; 2019; 8():. PubMed ID: 31824659
[TBL] [Abstract][Full Text] [Related]
33. A Functional Relationship Between UNC45A and MYO5B Connects Two Rare Diseases With Shared Enteropathy.
Li Q; Zhou Z; Sun Y; Sun C; Klappe K; van IJzendoorn SCD
Cell Mol Gastroenterol Hepatol; 2022; 14(2):295-310. PubMed ID: 35421597
[TBL] [Abstract][Full Text] [Related]
34. The localisation of the apical Par/Cdc42 polarity module is specifically affected in microvillus inclusion disease.
Michaux G; Massey-Harroche D; Nicolle O; Rabant M; Brousse N; Goulet O; Le Bivic A; Ruemmele FM
Biol Cell; 2016 Jan; 108(1):19-28. PubMed ID: 26526116
[TBL] [Abstract][Full Text] [Related]
35. Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease.
Kalashyan M; Raghunathan K; Oller H; Bayer MT; Jimenez L; Roland JT; Kolobova E; Hagen SJ; Goldsmith JD; Shub MD; Goldenring JR; Kaji I; Thiagarajah JR
J Clin Invest; 2023 Oct; 133(20):. PubMed ID: 37643022
[TBL] [Abstract][Full Text] [Related]
36. MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease.
Gonzales E; Taylor SA; Davit-Spraul A; Thébaut A; Thomassin N; Guettier C; Whitington PF; Jacquemin E
Hepatology; 2017 Jan; 65(1):164-173. PubMed ID: 27532546
[TBL] [Abstract][Full Text] [Related]
37. Bowel "dissection" in microvillus inclusion disease.
Chiang MC; Hsu JF; Hsueh C; Chao HC; Wang TH; Chen CP; Lai MW
Pediatr Neonatol; 2015 Apr; 56(2):129-31. PubMed ID: 23608388
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoids and myosin5b loss of function induce heightened PKA signaling in addition to membrane traffic defects.
Forteza R; Ahsan MK; Cartón-García F; Arango D; Ameen NA; Salas PJ
Mol Biol Cell; 2019 Dec; 30(26):3076-3089. PubMed ID: 31664880
[TBL] [Abstract][Full Text] [Related]
39. MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity.
Müller T; Hess MW; Schiefermeier N; Pfaller K; Ebner HL; Heinz-Erian P; Ponstingl H; Partsch J; Röllinghoff B; Köhler H; Berger T; Lenhartz H; Schlenck B; Houwen RJ; Taylor CJ; Zoller H; Lechner S; Goulet O; Utermann G; Ruemmele FM; Huber LA; Janecke AR
Nat Genet; 2008 Oct; 40(10):1163-5. PubMed ID: 18724368
[TBL] [Abstract][Full Text] [Related]
40. MYO5B Pathogenic Variants Found to Cause Intestinal Symptoms Without Microvillus Inclusion Disease in a Child Who Previously Underwent Liver Transplantation for PFIC-like Cholestasis.
Jarasvaraparn C; He M; Granadillo JL; Kulkarni S; Stoll J; Liss K
J Pediatr Gastroenterol Nutr; 2021 Jan; 72(1):e22-e24. PubMed ID: 32459745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
